Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ribosome Display Technology: Applications in Disease Diagnosis and Control
Adinarayana Kunamneni, Christian Ogaugwu, Steven B. Bradfute, et al.
Antibodies (2020) Vol. 9, Iss. 3, pp. 28-28
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization
Ji‐Wei Liu, Lei Wu, Anqi Xie, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Antibody display technologies: selecting the cream of the crop
Bernhard Valldorf, Steffen C. Hinz, Giulio Russo, et al.
Biological Chemistry (2021) Vol. 403, Iss. 5-6, pp. 455-477
Open Access | Times Cited: 99
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 28
Recombinant monoclonal antibody production in yeasts: Challenges and considerations
Prabir Kumar Das, Ansuman Sahoo, Venkata Dasu Veeranki
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131379-131379
Closed Access | Times Cited: 7
Phage Display Technology as a Powerful Platform for Antibody Drug Discovery
Kazuya Nagano, Yasuo Tsutsumi
Viruses (2021) Vol. 13, Iss. 2, pp. 178-178
Open Access | Times Cited: 49
Classical and emerging approximations for the screening of antimicrobial peptide libraries
Cristian F. Rodríguez, Valentina Quezada, Valentina Andrade-Pérez, et al.
Elsevier eBooks (2025), pp. 195-232
Closed Access
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Hybridoma technology: is it still useful?
Jane Zveiter de Moraes, Bárbara Hamaguchi, Camila Braggion, et al.
Current Research in Immunology (2021) Vol. 2, pp. 32-40
Open Access | Times Cited: 36
Antibody-receptor bioengineering and its implications in designing bioelectronic devices
Daphika S. Dkhar, Rohini Kumari, Supratim Mahapatra, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 225-242
Closed Access | Times Cited: 18
Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
Xuemei Feng, Hu Wang
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 925-942
Open Access | Times Cited: 10
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Recent advances of nanobody applications in diagnosis and detection
Qianling Su, Wei Shi, Xianing Huang, et al.
MedComm – Biomaterials and Applications (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 9
The impact of AlphaFold2 on experimental structure solution
Maximilian Edich, David C. Briggs, Oliver Kippes, et al.
Faraday Discussions (2022) Vol. 240, pp. 184-195
Open Access | Times Cited: 15
Cell-free Biosynthesis of Peptidomimetics
Kanghun Lee, Jessica Willi, Namjin Cho, et al.
Biotechnology and Bioprocess Engineering (2023) Vol. 28, Iss. 6, pp. 905-921
Open Access | Times Cited: 7
Phage Interactions with the Nervous System in Health and Disease
Adam Jędrusiak, Wojciech Fortuna, Joanna Majewska, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1720-1720
Open Access | Times Cited: 7
Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics
Qian Zhang, Nan Zhang, Han Xiao, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5639-5639
Open Access | Times Cited: 6
Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
Hamideh Raeisi, Masoumeh Azimirad, Hamid Asadzadeh Aghdaei, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 10
Targeting Ras with protein engineering
Atílio Tomazini, Julia M. Shifman
Oncotarget (2023) Vol. 14, Iss. 1, pp. 672-687
Open Access | Times Cited: 5
Production of a Ribosome-Displayed Mouse scFv Antibody Against CD133, Analysis of Its Molecular Docking, and Molecular Dynamic Simulations of Their Interactions
Sepideh Ghani, Mojgan Bandehpour, Fatemeh Yarian, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 3, pp. 1399-1418
Closed Access | Times Cited: 5
Production of Monoclonal Antibodies for Therapeutic Purposes: Applications, Techniques, and Improvement
Ziqi Ding, Yongqi Huang
(2024)
Open Access | Times Cited: 1
The Potential of Single‐Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics
Getachew Gezehagn Kussia, Tesfaye Sisay Tessema
Journal of Immunology Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Empowering gene delivery with protein engineering platforms
Monika Kizerwetter, Kevin Pietz, Luke M. Tomasovic, et al.
Gene Therapy (2022) Vol. 30, Iss. 12, pp. 775-782
Open Access | Times Cited: 7
FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
Christina Miller, Jennifer E. McGinnis, Michael J. Martinez, et al.
New Biotechnology (2021) Vol. 62, pp. 79-85
Open Access | Times Cited: 9
Synthetic Antiviral Peptides: A New Way to Develop Targeted Antiviral Drugs
Aura L. C. Parra, Leandro P. Bezerra, Dur E Shawar, et al.
Future Virology (2022) Vol. 17, Iss. 8, pp. 577-591
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top